The world’s first scientific prototype combining real time magnetic resonance imaging with proton therapy for tumours on the move with ‘made in Italy’ superconducting MgB2 technology is inaugurated in Germany (Dresden).
Monitoring cancer patients using real-time magnetic resonance images and significantly improving the accuracy of proton therapy: this is the goal that doctors from Saxony have set themselves together with scientists from the Helmholtz centre in Dresden-Rossendorf and Dresden university medicine in collaboration with ASG.
NEWS
More accurate tumour treatment thanks to superconductive ASG Superconductors technology
The world's first scientific prototype combining real time magnetic [...]
The Italian Health Minister Orazio Schillaci visiting MRopenEVO booth at RSNA 2023
Get ready for an exceptional week of learning and [...]
Marco Nassi appointed CEO of ASG Superconductors
ASG Superconductors SpA announces that the Board of Directors [...]
Smart Walking meets MROpen EVO
That's why we work everyday: the best mri experience [...]
MROpenEVO @ ARAB HEALTH 23
Spreading the best mri experience advantages enabled by MROpenEVO to [...]
Three new MROpen EVO in the USA
US Radiology Specialists Enhances Imaging Capabilities at its American [...]
DISCOVER MORE
